Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER

Metastatic Distal Bile Duct Adenocarcinoma

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Metastatic Distal Bile Duct Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Atezolizumab
Georgetown University
Phase 3BB
FLUOROURACILUM
AIO-Studien-gGmbH
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
AIO-Studien-gGmbH
Phase 2B
Irinotecan
AIO-Studien-gGmbH
Phase 2B
Cobimetinib
National Cancer Institute (NCI)
Phase 2CCC

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER is also rated in:

B-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
49 / 100
View asset →
Advanced Ovarian CarcinomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →